Hormone Receptor-positive Advanced Breast Cancer

• CLINICAL_TRIALS research · 2025-12-16
  Clinical Trial Update: Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer [Phase 2]

  Phase 2 trial update evaluating different doses of dalpicicl in combination with letrozole as first-line therapy for hormone receptor-positi…